Company intelligence / Profile preview

AuGC BioFund

San Diego, California, United States

Ownership: Private
Development stage: Other

Overview

AuGC BioFund is an equity hedge fund managed by AuGC Partners, specializing in value-oriented investments within the biotechnology sector. Founded in 2023, it is headquartered in San Diego, California, and does not engage in drug discovery or product development.

Industry: Investors

Beyond the preview

Go deeper on AuGC BioFund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AuGC BioFund.

Explore the full profile